Emyria Limited (ASX:EMD)
0.0360
-0.0020 (-5.26%)
At close: Mar 24, 2026
Emyria Market Cap
Emyria has a market cap or net worth of 29.04 million as of March 24, 2026. Its market cap has increased by 96.12% in one year.
Market Cap
29.04M
Enterprise Value
19.09M
Revenue
2.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since February 12, 2020, Emyria's market cap has increased from 26.67M to 29.04M, an increase of 8.89%. That is a compound annual growth rate of 1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 29.04M | -38.81% |
| Dec 31, 2025 | 47.45M | 203.01% |
| Dec 30, 2024 | 15.66M | -17.86% |
| Dec 29, 2023 | 19.06M | -61.44% |
| Dec 30, 2022 | 49.44M | -53.29% |
| Dec 31, 2021 | 105.86M | 410.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmX Technologies | 72.54M |
| Singular Health Group | 64.72M |
| Mach7 Technologies | 62.28M |
| PainChek | 60.61M |
| Beamtree Holdings | 42.14M |
| Vitasora Health | 40.73M |
| ImExHS | 21.35M |
| TrivarX | 19.61M |